|
||||
 |
The Voice of the American Psychiatric Association and the Psychiatric Community
| BACK TO NEWSLETTER | :: | CURRENT ISSUE | :: | PN ARCHIVES | :: | NEWS ALERT | :: | CONTACT US |
|
 |
 |
 |
University of Texas at Houston Reigns Supreme at MindGames
1. Atomoxetine is a selective reuptake inhibitor of what neurotransmitter? 2. Grapefruit juice inhibits this enzyme in the gut leading to higher levels of some medications Know the answers? (1. Norepinephrine; 2. Cytochrome P450). Those were just two of the questions residents from New York Presbyterian Hospital (Cornell Campus), the University of Texas at Houston, and New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric Institute answered last night during this year’s MindGames competition, the fun and entertaining “Jeopardy”-like competition, moderated by Glen Gabbard, M.D., that pits psychiatrists from residency programs around the country against each other. University of Texas at Houston walked away with the honors at last night’s Mind Games competition. Pictured above are Connie Zajicek, M.D., Melissa Allen, M.D., and Garima Arora, M.D. The residency director at Houston is Vineth John, M.D. MindGames is open to all residency programs in the United States and Canada. The competition begins during the last two weeks of February, when teams of three residents each take a 60-minute online examination consisting of 100 multiple-choice questions. The questions follow the ABPN  Part I content outline. Watch a video of the exciting conclusion of MindGames. |
|
Copyright © 2012 American Psychiatric Association. All rights reserved.